These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27239048)

  • 1. Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.
    Kropshofer G; Sopper S; Steurer M; Schwinger W; Crazzolara R
    Am J Hematol; 2016 Sep; 91(9):E357-8. PubMed ID: 27239048
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed chimerism after bone marrow transplantation for thalassemia major.
    Li CK; Chik KW; Tsang KS; Pong H; Shing MM; Yuen PM
    Haematologica; 2002 Jul; 87(7):781-2. PubMed ID: 12091135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch from beta-thalassemia major to beta-thalassemia intermedia after secondary graft failure.
    Mellouli F; Ksouri H; Lakhal A; Torjmen L; Abdelkefi A; Ladeb S; Hmida S; Othman TB; Béjaoui M
    Exp Clin Transplant; 2010 Sep; 8(3):269-71. PubMed ID: 20716049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major.
    Spitzer B; Giardina PJ; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2015 Jul; 62(7):1303-4. PubMed ID: 25810133
    [No Abstract]   [Full Text] [Related]  

  • 6. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed donor chimerism in non-malignant haematological diseases after allogeneic bone marrow transplantation.
    Shamshad GU; Ahmed S; Bhatti FA; Ali N
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):765-8. PubMed ID: 23217481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of thalassemia major with unrelated donor bone marrow transplantation].
    Zhu WG; Feng ZC; Lan HK; Zhang CC; Li QP; Li ZD
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):599-602. PubMed ID: 16191272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli).
    Hongeng S; Chuansumrit A; Hathirat P; Rerkamnuaychoke B; Chaisiripoomkere W; Jootar S
    Bone Marrow Transplant; 2002 Sep; 30(6):409-10. PubMed ID: 12235528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders.
    Kottaridis PD; Peggs K; Lawrence A; Verfuerth S; Chatterjee R; Telfer P; Porter JB; Mackinnon S; Goldstone AH
    Bone Marrow Transplant; 2000 Mar; 25(6):677-8. PubMed ID: 10734304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-mismatched bone marrow transplantation in thalassemia.
    Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M
    Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed chimerism after bone marrow transplantation in thalassemia.
    Nesci S; Manna M; Lucarelli G; Tonucci P; Donati M; Buffi O; Agostinelli F; Andreani M
    Ann N Y Acad Sci; 1998 Jun; 850():495-7. PubMed ID: 9668594
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation.
    Andreani M; Nesci S; Lucarelli G; Tonucci P; Rapa S; Angelucci E; Persini B; Agostinelli F; Donati M; Manna M
    Bone Marrow Transplant; 2000 Feb; 25(4):401-4. PubMed ID: 10723583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of chimerism monitoring and donor lymphocyte infusion in eliminating the risk of graft rejection following HSCT in thalassemia patients-review].
    Li ZF; Sun X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1356-60. PubMed ID: 24156465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor lymphocyte infusion reversed graft rejection in matched-unrelated donor hematopoietic stem cell transplantation for a child with thalassemia.
    Liu APY; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
    Ann Hematol; 2017 Jul; 96(7):1205-1206. PubMed ID: 28432411
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful management of impending late graft failure in a thalassemic bone marrow transplant recipient.
    Zakrzewski JL
    Haematologica; 2002 Oct; 87(10):ECR32. PubMed ID: 12368175
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism.
    Or R; Kapelushnik J; Naparstek E; Nagler A; Filon D; Oppenheim A; Amar A; Aker M; Samuel S; Slavin S
    Br J Haematol; 1996 Aug; 94(2):285-7. PubMed ID: 8759888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.